In an Aug. 7 earnings call, Eli Lilly CEO David Ricks told investors that the company plans to submit the drug, orforglipron, to the FDA for approval by the end of the year. Dan Skovronsky, chief ...

NPR's Scott Simon speaks to Dave Jorgenson, the creator of the Washington Post's TikTok channel, about his new media organization and the future of short-form content in newsrooms. Let's take a step ...